iRegene’s Parkinson’s therapy gains FDA designation
The RMAT designation accelerates the development of regenerative medicine therapies for serious or life-threatening diseases
The RMAT designation accelerates the development of regenerative medicine therapies for serious or life-threatening diseases
The Eugene facility, with more than 20 years of history, houses a 16,000-square-foot R&D lab and a newly constructed 30,000-square-foot manufacturing facility
The launch of PatroLab is a pivotal milestone, marking a paradigm shift in biologics development and manufacturing
The collaboration gives Axolabs access to Codexis’ innovative RNA manufacturing technology
Developed using STEERLife’s proprietary FragMelt continuous processing platform, the approval marks a major breakthrough in pharmaceutical manufacturing
BFF provides bookable fermentation upscaling capacity, process expertise, and quality procedures for pilot campaigns, generating decision-grade data without companies needing to build their own facilities
Supports production of AbbVie's current and next-generation immunology and neuroscience medicines
New 35,000-square-foot facility in Winter Park will expand RLT manufacturing footprint to optimize delivery for patients across southeastern US
Subscribe To Our Newsletter & Stay Updated